RESULTS: A total of 198 men (mean age 35AE8 years) were included. Fertilization and pregnancy rates were 44% and 38%, respectively. On univariable analysis, sperm motility and the lack of acrosome defects were associated with higher fertilization and pregnancy rates while an increasing number of total sperm abnormalities was negatively associated with fertilization, but not pregnancy, rates (Table) . On MVA, only sperm motility was associated with fertilization rates (p<0.001) while both sperm motility (p¼0.004) and the lack of acrosome abnormalities (p¼0.018) were associated with pregnancy rates. Female age (mean age 31AE5 years) was not associated with fertilization or pregnancy rates on MVA.
INTRODUCTION AND OBJECTIVES: Congenital absence of vas deferens (CAVD) causes obstructive azoospermia in 1% of infertile men and can be treated using epididymal sperm aspiration (MESA) coupled with intracytoplasmic sperm injection (IVF/ICSI). CAVD can be seen in patients with and without mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. There is an ongoing debate about whether CFTR mutations affect spermatogenesis. We hypothesized that CFTR mutations in men with CAVD would negatively affect reproductive outcomes.
METHODS: We retrospectively reviewed a database of 78 infertile men with CAVD who were treated by a single surgeon from 1990 to 2016. Information on demographics, phenotype, CFTR mutations, and IVF/ICSI outcomes were collected. Patients with CFTR mutations (CFTR+) and without CFTR mutations (CFTR-) were compared using Fisher test and unpaired t-test, with significance set at p<0.05.
RESULTS: We identified 65 men with CAVD who were screened for CFTR mutations, of whom 34 had bilateral CAVD and underwent MESA and IVF/ICSI at our institution. Average patient and partner ages were 33AE6 years and 31AE5 years, respectively. 36 patients (55%) were CFTR+ while 29 patients (45%) were CFTR-. 92% of CFTR+ patients presented with bilateral CAVD compared to 79% of . Renal anomalies were only seen in CFTR-patients (Table) . Amongst CFTRpatients, 50% with unilateral CAVD and 35% with bilateral CAVD had renal anomalies (p¼0.65). The most common CFTR mutation detected was Df508 (50%), followed by w1882x (22%) and 5t (17%). 24 CFTR+ couples underwent 47 IVF/ICSI cycles and 10 CFTR-couples underwent 13 IVF/ ICSI cycles. While fertilization rates were higher in CFTR-patients, there was no difference in clinical pregnancy or live birth rates (Table) .
CONCLUSIONS: Men with CAVD present evenly with and without CFTR mutations. CFTR-patients are more likely to harbor renal anomalies and should be screened while CFTR+ patients do not need to be screened for renal anomalies. While CFTR mutations negatively affect fertilization rates, there was no difference in clinical pregnancy or live birth rates after IVF/ICSI. Further studies with larger populations that examine the relationship between specific CFTR mutations and reproductive outcomes are warranted to substantiate our findings.
Source of Funding: Supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust.
PD68-05 THE OUTCOMES OF SCROTAL EXPLORATION WITH VASOEPIDIDYMOSTOMY IN PATIENTS WITH NON-IATROGENIC, NON-TRAUMATIC OBSTRUCTIVE AZOOSPERMIA
Chin Heng Lu*, William J. S. Huang, I-Shen Huang, Alex T. L. Lin, Kuang-Kuo Chen, Taipei, Taiwan INTRODUCTION AND OBJECTIVES: Non-iatrogenic, nontraumatic obstructive azoospermia (OA) includes causes like congenital bilateral absence of vas deferens (CBAVD), blockage at rete testis, or obstruction distal to internal inguinal rings. The blockage could be potentially identified at scrotal exploration and corrected with vasoepididymostomy (VE). The purpose of this study is to analyze patients with non-iatrogenic, non-traumatic OA who underwent scrotal exploration with or without VE anastomosis in our institution. (49), bilateral intra-abdominal blockage (7), CBAVD variants (3). There were 68 patients received VE anastomosis. The patency rates 6 months after operation for patients with bilateral epididymal blockage were 88%. They were 90.9% for blockage at both epididymal tails, 88.9% at body, and 83.3% at head. Motile sperm in perioperational cutting end fluid aspiration had patency rates at 80.6%, in contrary they were 50% in cases showing only immotile sperm. The mean patency rates were 79.5% for all cases 6 months after operation. There were 28.1% of patients failed to have correction procedure, including 25% of high or low blockage, and 3.1% of CBAVD variants. Patients with CBAVD variants showed lower semen pH (6.67AE0.1, P¼ 0.001).
CONCLUSIONS: For patients with non-iatrogenic non-traumatic OA receiving scrotal exploration, 28.1% are not eligible for correction. The mean patency rates for all patients 6 months after microanastomosis were 79.5%. They were 90.9% and 88% for cases with obstruction at bilateral epididymal tails and body respectively. Motile sperm in proximal end predict higher patency rates.
Source of Funding: none

PD68-06 TEACHING THE TEACHERS: AN EDUCATIONAL PROGRAM FOR MANAGEMENT OF INFERTILITY IN MEN WITH SPINAL CORD INJURY
Emad Ibrahim*, Teodoro Aballa, Charles Lynne, Nancy Brackett, Miami, FL INTRODUCTION AND OBJECTIVES: Spinal cord injury (SCI) occurs most often to young men. Infertility is a major sequela of SCI. Anejaculation and abnormal semen parameters are seen in 90% of the cases. Currently there is no established standard of care for the management of infertility in these men, largely due to a lack of education of healthcare providers at all levels. Consequently, couples with SCI male partners are often over-treated with expensive and unnecessary procedures. A 3 year educational program funded by the Craig Neilsen Foundation has been developed to train practitioners in methods and techniques for managing infertility in this population.
METHODS: A teaching curriculum was developed based on our 27 years of experience in the management of infertility in men with SCI. The training is performed at our center or at outside centers if requested and is comprised of the following items:
1) The core of the curriculum is a half day of lectures and videos 2) Two half-days of hands-on training on the techniques of penile vibratory stimulation (PVS) and electroejaculation (EEJ) as well as management of autonomic dysreflexia and retrograde ejaculation. This is part of the training curriculum at our site and can be performed at other sites if the users so wish. 3) A syllabus, copy of the PowerPoint presentation and instructional videos will be supplied to trainees which may be used to teach future healthcare providers of all types. 4) The program offers Continuing Medical Education (CME) credits (7.5 hours for the full course) for physicians. 5) Limited travel reimbursement is available for professionals who train at our center in Miami.
RESULTS: During our first year (December 2015 -December 2016), educational materials (syllabus and comprehensive 30 minute instructional video) were developed. The program was presented at the Academy of Spinal Cord Injury Professionals (ASCIP) 2016 meeting and has been selected as an instructional course for the 2017 annual AUA meeting. A total of 9 physicians from the USA, Canada, Spain, Brazil and Israel have been trained to date at our center. Multiple requests for training have been received and are scheduled for future dates.
CONCLUSIONS: This educational program addresses a gap in knowledge among health care professionals on the topic of management of infertility in men with SCI. We encourage interested professionals to take advantage of this training opportunity, which will be available through December 2018. METHODS: We surveyed the 75 major academic medical centers as ranked for research in 2016 by U.S. News & World Report using a questionnaire based telephone/web survey. We gathered data on presence and content of posthumous sperm retrieval policies. If not published, we contacted the legal counsel for the medical center, the ethics and compliance offices, the Urology Department, as well as the infertility center for each institution, in that order.
RESULTS: Out of the 75 major academic medical centers, we gathered data on posthumous sperm retrieval from 25 (33.3%). Of the 25 institutions, nine (36%) had policies regarding posthumous sperm retrieval, fifteen (60%) did not have a policy, and one center remained undisclosed. Five of the fifteen medical centers without policies have discussed development of a policy but did not formalize it due to lack of legal guidance as a barrier to policy adoption. Out of the nine centers that had a policy, four required prior written consent, while five allowed for verbal or inferred consent from the surviving life partner.
CONCLUSIONS: Very few, about 1/3, of the surveyed academic medical centers have policies on posthumous sperm retrieval. Medical centers can adopt individualized policies based on guidelines published by the American Society for Reproductive Medicine.
